# EDGAR Filing Document

**Accession Number:** 0001373604
**File Stem:** 0001373604-25-000092
**Filing Date:** 2025-6
**Character Count:** 6921
**Document Hash:** 80ccefdce98c894a11b808ef7c0ae800
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001373604-25-000092.hdr.sgml**: 20250618

**ACCESSION NUMBER**: 0001373604-25-000092

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250618

**DATE AS OF CHANGE**: 20250618

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AN2 Therapeutics, Inc.
- **CENTRAL INDEX KEY:** 0001880438
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 820606654
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-93617
- **FILM NUMBER:** 251055520

**BUSINESS ADDRESS:**
- **STREET 1:** 1800 EL CAMINO REAL, SUITE D
- **CITY:** MENLO PARK
- **STATE:** CA
- **ZIP:** 94027
- **BUSINESS PHONE:** (650) 331-9090

**MAIL ADDRESS:**
- **STREET 1:** 1800 EL CAMINO REAL, SUITE D
- **CITY:** MENLO PARK
- **STATE:** CA
- **ZIP:** 94027
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BML Investment Partners, L.P.
- **CENTRAL INDEX KEY:** 0001373604

**ORGANIZATION NAME:**
- **EIN:** 383708345
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **STREET 1:** 65 E CEDAR - SUITE 2
- **CITY:** ZIONSVILLE
- **STATE:** IN
- **ZIP:** 46077
- **BUSINESS PHONE:** 317-344-2447

**MAIL ADDRESS:**
- **STREET 1:** 65 E CEDAR - SUITE 2
- **CITY:** ZIONSVILLE
- **STATE:** IN
- **ZIP:** 46077

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 2)**

**AN2 Therapeutics, Inc.**

*(Name of Issuer)*

**Common Stock, par value $0.00001 per share**

*(Title of Class of Securities)*

**037326105**

*(CUSIP Number)*

**Braden Leonard**<br>65 E Cedar - Suite 2<br>Zionsville IN 46077<br>317-344-2447

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**06/17/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **037326105** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**BML Investment Partners, L.P.** | Name of reporting person<br>**BML Investment Partners, L.P.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**427432.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**427432.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**427432.00** | Aggregate amount beneficially owned by each reporting person<br>**427432.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**1.4%** | Percent of class represented by amount in Row (11)<br>**1.4%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, par value $0.00001 per share

**(b) Name of Issuer:**
AN2 Therapeutics, Inc.

**(c) Address of Issuer's Principal Executive Offices:**
1800 El Camino Real, Suite D, Menlo Park, CA, 94027

**Item 4. Purpose of Transaction**

The Reporting Persons purchased the Common Stock reported hereunder for investment purposes, and such purchases were made in the Reporting Persons' ordinary course of business. As with their other investments, the Reporting Persons continuously evaluate the Issuer, including but not limited to its businesses, results of operations, and prospects.

All the shares of Common Stock reported herein as being beneficially owned by the Reporting Persons were acquired for investment purposes. Except as set forth herein, none of the Reporting Persons has any plans or proposals that related to or would result in any of the transactions described in Item 4 of Schedule 13D.

The Reporting Persons reserve the right to acquire, or cause to be acquired, additional securities of the Issuer, to dispose of, or cause to be disposed, such securities at any time or to formulate other purposes, plans or proposals regarding the Issuer or any of its securities, to the extent deemed advisable in light of general investment and trading policies of the Reporting Persons, market conditions or other factors.

**Item 5. Interest in Securities of the Issuer**

**(a)**
BML Investment Partners, L.P. beneficially owns 427,432 shares of the Issuer's Common Stock, or 1.4%.

**(b)**
427,432

**(c)**
BML Investment Partners, L.P.

5/28/25 Sold 2,000,000 at $1.16
5/28/25 Sold  100,000 at $1.16
5/30/25 Sold   425,000 at $1.01
5/30/25 Sold   7,000 at $1.0324
6/12/25 Sold 200,000 at $1.09
6/17/25 Sold 2,590,000 at $1.12

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

To the best of the knowledge of the Reporting Persons, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the Reporting Persons or between the Reporting Persons and any person with respect to any securities of the Issuer, including but not limited to transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** BML Investment Partners, L.P.

**Signature:** Braden M Leonard

**Name/Title:** Braden M Leonard - Managing Member of BML Capital Management, LLC

**Date:** 06/18/2025